Active Stimulation ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
46Malignant rheumatoid arthritis2

46. Malignant rheumatoid arthritis


Clinical trials : 4,325 Drugs : 2,671 - (DrugBank : 417) / Drug target genes : 187 - Drug target pathways : 224
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT05003310
(ClinicalTrials.gov)
October 19, 20215/7/2021Splenic Stimulation for RAMultipart Exploratory Study to Evaluate Splenic Nerve Stimulation in Patients With Rheumatoid ArthritisRheumatoid ArthritisDevice: Active Stimulation;Device: Sham Stimulation;Drug: Baricitinib;Drug: Background TreatmentGalvani BioelectronicsNAMSA;Q2 SolutionsRecruiting22 Years75 YearsAll28N/AUnited States
2NCT04539964
(ClinicalTrials.gov)
January 11, 202131/8/2020Vagus Nerve Stimulation for Moderate to Severe Rheumatoid ArthritisVagus Nerve Stimulation Using the SetPoint System for Moderate to Severe Rheumatoid Arthritis: The RESET-RA StudyRheumatoid ArthritisProcedure: Implant Procedure;Drug: Conventional Synthetic DMARD;Device: Active stimulation;Device: Non-active stimulationSetPoint Medical CorporationNULLRecruiting22 Years75 YearsAll250Phase 3United States